Tom Winnifrith’s sixth share tip of the year 2015, buy Premaitha at a 19.5p offer

Comments

1. ---

   Maurice Waldman

   1 January 2015, 07:19

   I am a scientist. And have bought a substantial amount into this company on the grounds of its board, evidence and ethos.
   I would expect 50p SP for starters. In my opinion. This is based on the price where the board gets paid.

2. ---

   handybrownone

   2 January 2015, 08:16

   Tom – nice tip thanks. I am a scientist too and a patent attorney – all of these oil stocks I am out to sea with but these sort of companies I like. BTW Optio tip was also good but sol out a little too soon. Will watch for any weakness and re-enter. The CE marking process i very quick and predictable and not expensive they seem convinced it will happen in Jan – i am not si sure timings are so predictable but… Recently a friend of a friend suffered a miscarriage following an amniotic test (which was negative) – so they lost their child who was healthy. A 1% risk APPEARS low when you think about gambling but for a pregnant mum it is unacceptable. I imagine the ets should come in at less than the scan (which is done anyway + the amnio – which not everyone goes for). It is tragic and there is a long felt need for such a test. Only a quick look sees some disconnect with the USA – where it is suggested in the admission document that companies already offer this type of test not much info given? Also the freedom-to-operate analysis does not include USA and it is very clear from the Stockopedia video on Youtube with the CEO that he sees it as a foot race in Europe (no plans for USA?). In the market analysis they include USA. Anyway I think I am in – for a little and see how it goes. If I have time will read through the patents. I don’t think they are going to be the only company offering this but as he says there is real value in being first and also tieing up the suppliers etc etc.As you say quality board….

3. ---

   handybrownone

   5 January 2015, 08:58

   Tom – the basic patent for the Down’s screening is stated to be WO2014033455 to Zoragen due to be assigned to the company – it has a search report available and on the face of it the claims as presented won’t be granted due to GB2485635 (+ anther journal reference) which is filed by Verinata. If you look for Verinata they offer service in the UK and it is currently changing to Illumina which when you look at the US website offers many DNA services including a prenatal screening test based upon a blood sample from 10 weeks – results in 6 days. It can do three chromosome trisomy tests not just Downs better?

   http://www.illumina.com/clinical/reproductive-genetic-health/clinical-labs/nipt.html.

   So I think my first reaction was correct – it is a foot race to the EU market. Since CE submissions are not public until approved then there is no certainty as to where Illumina fits or any other company. BTW GB2485635B is granted and in force. I assume that in fact Premaitha is similar but avoids the patent as they say they have a FTO report. The granted claims are

   http://www.ipo.gov.uk/p-ipsum/Document/ApplicationNumber/GB1114713.9/H8B8KW1CWYX6AVQ/GB2485635-20121008-Claims.pdf

   They look quite broad but I don’t have enough information.

4. ---

   wildrides

   5 January 2015, 09:16

   I am not a scientist …………….. Just thought you would like to know .

   But I have made a nice wedge already on this share thanks to Tom .

   Cant wait for a post that starts “ I am a dustman” ( but only on Wednesdays and Fridays due to budget cuts )

5. ---

   Ac

   5 January 2015, 14:14

   Hi Tom, do you have any thoughts on whether Premaitha might be able to accelerate take up of the Iona test, perhaps with a tie up with a bigger third party or similar? Or would you think it more likely that it will be lab by lab growth. Just for the record, I am not a scientist either.

6. ---

   handybrownone

   6 January 2015, 01:53

   Wildrides- a dustman twice a week you are lucky. I’m less excited now so sold a few off and will see. No doubt the CE news will cause a rise. Then there will be a long slow decline in SP as PIs realise its not selling billions in the first week. To think that no one else has submitted is unlikely. The Illumina test does three chromosomal abnormalities in one test in the USA that works from 10 weeks and offers results in 6 days (that is the time from sending the sample in to you getting the results back) and they have a UK subsidiary. I think the build is longer than you think and the unknowns are just too unknown. How well does Iona perform?

7. ---

   handybrownone

   16 March 2015, 01:31

   Oh dear sued for patent infringement – the claims from Illumina are broad. NIPT said that had a freedon-to-operate opinion but that is worth nothing. Illumina are suing anywya and if you think about it logically it means

   1) muscling NIPT into a spot to get something back
   2) closing them down – a win in the UK will mean no one will touch it anywhere in Europe.
   3) their product is just behind? Causing doubt and everyone switching

   I hope the BOD dont get too emotional and get practical

8. ---

   wildrides

   16 March 2015, 01:59

   Handy brown one ( hope its not a floater )

   I sold out a few weeks ago ……….. sounds like a good job if they are getting sued . Why no RNS from the board about litigation I wonder ………. shocking .